🇺🇸 FDA
Patent

US 9339528

Methods for treating epithelium trauma of the intestinal mucosa using interleukin-1 receptor antagonist

granted A61KA61K38/1709A61K38/2006

Quick answer

US patent 9339528 (Methods for treating epithelium trauma of the intestinal mucosa using interleukin-1 receptor antagonist) held by GENERAL REGENERATIVES, LTD. expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GENERAL REGENERATIVES, LTD.
Grant date
Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/1709, A61K38/2006, A61P, A61P1/00